Emergent BioSolutions, Inc. (EBS)
7.995
-0.08
(-1.05%)
USD |
NYSE |
Mar 18, 15:59
8.01
+0.02
(+0.19%)
After-Hours: 19:55
Emergent BioSolutions Total Liabilities (Quarterly) : 809.40M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 19.20B |
| Eli Lilly & Co. | 85.94B |
| Penumbra, Inc. | 398.92M |
| Disc Medicine, Inc. | 67.05M |
| MetaVia, Inc. | 8.434M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.332B |
| Shareholders Equity (Quarterly) | 522.60M |
| Debt to Equity Ratio | 1.117 |
| Current Ratio | 5.011 |
| Net Debt Paydown Yield | 2.87% |